MCP
AGN

Maso Capital Partners’s Allergan plc AGN Stock Holding History

Maso Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-627,016
Closed -$111M – 24
2020
Q1 		$111M Buy
627,016
+289,296
+86% +$54.5M 28.76% 1
2019
Q4 		$64.6M Buy
337,720
+189,720
+128% +$34.2M 20.76% 1
2019
Q3 		$24.9M Buy
+148,000
New +$24.1M 8.95% 5

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Maso Capital Partners's AGN Position: Q2 2020 in Review

Maso Capital Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 627,016 shares — an estimated $111M sold.

Maso Capital Partners first reported a position in AGN in Q3 2019 and held it in 3 quarters. The position peaked at $111M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Maso Capital Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Maso Capital Partners sold 627,016 Allergan plc shares in Q2 2020, an estimated $111M.
  • Maso Capital Partners first reported a position in Allergan plc in Q3 2019 and held it in 3 quarters.
  • Maso Capital Partners's Allergan plc position peaked at $111M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Maso Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.